Cargando…

Potassium Iodide Tablets Instead of a Saturated Solution Preoperatively for Reaching Euthyroidism Quickly in Refractory Graves’ Disease

The optional use of a saturated solution of potassium iodide in the immediate preoperative period to reach euthyroidism is included both in the American Thyroid Association (ATA) and in the European Thyroid Association (ETA) guidelines for the treatment of Graves’ disease (GD). The recent literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiapponi, Costanza, Schmidt, Matthias, Faust, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301294/
https://www.ncbi.nlm.nih.gov/pubmed/34327081
http://dx.doi.org/10.7759/cureus.15854
_version_ 1783726634785832960
author Chiapponi, Costanza
Schmidt, Matthias
Faust, Michael
author_facet Chiapponi, Costanza
Schmidt, Matthias
Faust, Michael
author_sort Chiapponi, Costanza
collection PubMed
description The optional use of a saturated solution of potassium iodide in the immediate preoperative period to reach euthyroidism is included both in the American Thyroid Association (ATA) and in the European Thyroid Association (ETA) guidelines for the treatment of Graves’ disease (GD). The recent literature though, shows that it does not translate to more clinically meaningful differences in surgical outcome. In our experience, potassium iodide should not be seen as a means for reducing operative time or complications; it is an effective way for reaching euthyroidism quickly. Herein, we describe three selected cases in which concentrated potassium iodide 65 mg tablets - instead of a saturated solution - were administered for thyroid blocking preoperatively, as recommended in the event of a nuclear emergency. One of the patients was pregnant. After oral treatment with potassium iodide 130 mg daily (two pills), euthyroidism was reached in all three cases within 24 hours. There were no side effects and surgery was performed without complications. Although the current literature did not report a significant benefit concerning operative time and complications, in our opinion preoperative potassium iodide plays an important role in selected cases for reaching euthyroidism preoperatively quickly. Potassium iodide 65 mg tablets, which are recommended in case of a nuclear emergency, are a very effective alternative to saturated solutions, which are not always quickly available and generally need to be administered over seven to 10 days.
format Online
Article
Text
id pubmed-8301294
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-83012942021-07-28 Potassium Iodide Tablets Instead of a Saturated Solution Preoperatively for Reaching Euthyroidism Quickly in Refractory Graves’ Disease Chiapponi, Costanza Schmidt, Matthias Faust, Michael Cureus Anesthesiology The optional use of a saturated solution of potassium iodide in the immediate preoperative period to reach euthyroidism is included both in the American Thyroid Association (ATA) and in the European Thyroid Association (ETA) guidelines for the treatment of Graves’ disease (GD). The recent literature though, shows that it does not translate to more clinically meaningful differences in surgical outcome. In our experience, potassium iodide should not be seen as a means for reducing operative time or complications; it is an effective way for reaching euthyroidism quickly. Herein, we describe three selected cases in which concentrated potassium iodide 65 mg tablets - instead of a saturated solution - were administered for thyroid blocking preoperatively, as recommended in the event of a nuclear emergency. One of the patients was pregnant. After oral treatment with potassium iodide 130 mg daily (two pills), euthyroidism was reached in all three cases within 24 hours. There were no side effects and surgery was performed without complications. Although the current literature did not report a significant benefit concerning operative time and complications, in our opinion preoperative potassium iodide plays an important role in selected cases for reaching euthyroidism preoperatively quickly. Potassium iodide 65 mg tablets, which are recommended in case of a nuclear emergency, are a very effective alternative to saturated solutions, which are not always quickly available and generally need to be administered over seven to 10 days. Cureus 2021-06-23 /pmc/articles/PMC8301294/ /pubmed/34327081 http://dx.doi.org/10.7759/cureus.15854 Text en Copyright © 2021, Chiapponi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Anesthesiology
Chiapponi, Costanza
Schmidt, Matthias
Faust, Michael
Potassium Iodide Tablets Instead of a Saturated Solution Preoperatively for Reaching Euthyroidism Quickly in Refractory Graves’ Disease
title Potassium Iodide Tablets Instead of a Saturated Solution Preoperatively for Reaching Euthyroidism Quickly in Refractory Graves’ Disease
title_full Potassium Iodide Tablets Instead of a Saturated Solution Preoperatively for Reaching Euthyroidism Quickly in Refractory Graves’ Disease
title_fullStr Potassium Iodide Tablets Instead of a Saturated Solution Preoperatively for Reaching Euthyroidism Quickly in Refractory Graves’ Disease
title_full_unstemmed Potassium Iodide Tablets Instead of a Saturated Solution Preoperatively for Reaching Euthyroidism Quickly in Refractory Graves’ Disease
title_short Potassium Iodide Tablets Instead of a Saturated Solution Preoperatively for Reaching Euthyroidism Quickly in Refractory Graves’ Disease
title_sort potassium iodide tablets instead of a saturated solution preoperatively for reaching euthyroidism quickly in refractory graves’ disease
topic Anesthesiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301294/
https://www.ncbi.nlm.nih.gov/pubmed/34327081
http://dx.doi.org/10.7759/cureus.15854
work_keys_str_mv AT chiapponicostanza potassiumiodidetabletsinsteadofasaturatedsolutionpreoperativelyforreachingeuthyroidismquicklyinrefractorygravesdisease
AT schmidtmatthias potassiumiodidetabletsinsteadofasaturatedsolutionpreoperativelyforreachingeuthyroidismquicklyinrefractorygravesdisease
AT faustmichael potassiumiodidetabletsinsteadofasaturatedsolutionpreoperativelyforreachingeuthyroidismquicklyinrefractorygravesdisease